Liu Shan, Xiong Xiaoliang, Hao Tingting, Shi Xue, Zhao Yinlong
Department of Nuclear Medicine, The Second Hospital of Jilin University, Changchun, China.
Front Endocrinol (Lausanne). 2025 Jun 30;16:1536155. doi: 10.3389/fendo.2025.1536155. eCollection 2025.
Thyroid cancer is a prevalent malignancy with a rising global incidence, driven by factors such as genetic mutations, environmental influences, and gender differences. Despite advancements in diagnostic techniques and treatments, effective therapies for advanced or iodine-refractory thyroid cancer remain limited. Recent discoveries have challenged the long-held belief that tumors are sterile, revealing the presence of intratumor microbiota in various cancers. Intratumor microbiota significantly impact cancer development, immune reactions, and the effectiveness of treatments. This review examines the emerging evidence of intratumor microbiota in thyroid cancer, emphasizing their potential roles in tumor development. We also examine the origins and diversity of these microbial communities and investigate the mechanisms through which they might affect thyroid cancer progression. Understanding the complex interactions between intratumor microbiota and thyroid cancer could inform the development of novel diagnostic tools and therapeutic strategies to improve patient outcomes.
甲状腺癌是一种常见的恶性肿瘤,受基因突变、环境影响和性别差异等因素驱动,全球发病率呈上升趋势。尽管诊断技术和治疗方法有所进步,但针对晚期或碘难治性甲状腺癌的有效疗法仍然有限。最近的发现挑战了长期以来认为肿瘤是无菌的观念,揭示了多种癌症中存在肿瘤内微生物群。肿瘤内微生物群对癌症发展、免疫反应和治疗效果有显著影响。本综述探讨了甲状腺癌中肿瘤内微生物群的新证据,强调了它们在肿瘤发展中的潜在作用。我们还研究了这些微生物群落的起源和多样性,并探讨了它们可能影响甲状腺癌进展的机制。了解肿瘤内微生物群与甲状腺癌之间的复杂相互作用,可为开发新的诊断工具和治疗策略提供依据,以改善患者的治疗效果。